{"database": "lobbying", "table": "lobbying_activities", "rows": [[1988124, "37443b5d-7728-47df-857b-af71348d9cd4", "Q2", "ROCK & ASSOCIATES", 33545, "WOMEN'S INTERNATIONAL PHARMACY", 2017, "second_quarter", "PHA", "Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  H.R. 2871, Patient Access to Compounded Medications Act of 2017.", "HOUSE OF REPRESENTATIVES,SENATE", 11250, null, 0, 0, "2017-07-15T11:12:43.823000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1988124"], "units": {}, "query_ms": 28.442210983484983, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}